
07/24/2025
Since Dan became our first patient with Alzheimer’s disease at Cleveland Clinic Lou Ruvo Center for Brain Health to receive the drug, lecanemab, in a clinical setting, we’re celebrating the completion of his 18-month course of treatment!
More on why this drug is giving Dan and his family hope and what this means for those living with early-stage disease: https://cle.clinic/485Sk5F